In the immediate aftermath of lockdown measures and travel restrictions, pharma teams initially relied on video calls to meet and collaborate. But this quickly became unwieldy due to the ongoing, multi-stakeholder nature of work across medical affairs, clinical, and commercial divisions. And the pharma strategy in 2021, one-off meetings via video platforms quickly dropped off […]
